moxonidin ratiopharm 0.4 mg tabletti, kalvopäällysteinen
teva b.v. - moxonidine - tabletti, kalvopäällysteinen - 0.4 mg - moksonidiini
letrolan 2.5 mg tabletti, kalvopäällysteinen
avansor pharma oy - letrozole - tabletti, kalvopäällysteinen - 2.5 mg - letrotsoli
ibandronat sanoswiss 50 mg tabletti, kalvopäällysteinen
sanoswiss uab sanoswiss uab - happo ibandronicum - tabletti, kalvopäällysteinen - 50 mg - ibandronihappo
ibandronat sanoswiss 150 mg tabletti, kalvopäällysteinen
sanoswiss uab sanoswiss uab - happo ibandronicum - tabletti, kalvopäällysteinen - 150 mg - ibandronihappo
heplisav b
dynavax gmbh - hepatiitti b-pinta-antigeeni - b-hepatiitti - rokotteet - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.